NCT06458517View on ClinicalTrials.gov

Evaluation of Two Methods of Administration of Photobiomodulation in the Context of the Prevention and Treatment of Mucositis Induced by Radiotherapy, During the Treatment of Head and Neck Cancers

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 2, 2024

Primary Completion Date

May 2, 2026

Study Completion Date

May 2, 2026

Conditions
Head and Neck Neoplasms
Interventions
DEVICE

Photobiomodulation session - intraoral

use of CareMin650TM lightbox(NeoMedLight) in preventive and in case of occurence of grade 1 oral mucositis, in curative purpose

DEVICE

Photobiomodulation session - transcutaneous

use of ATP38® phototherapy device (Swiss Bio Inov Europe) in preventive and in case of occurence of grade 1 oral mucositis, in curative purpose

Trial Locations (1)

67033

Institut de cancérologie Strasbourg Europe, Strasbourg

All Listed Sponsors
lead

Institut de cancérologie Strasbourg Europe

OTHER

NCT06458517 - Evaluation of Two Methods of Administration of Photobiomodulation in the Context of the Prevention and Treatment of Mucositis Induced by Radiotherapy, During the Treatment of Head and Neck Cancers | Biotech Hunter | Biotech Hunter